CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President & CEO acquired 4,500 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 417 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,423 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 1,702 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 2,150 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,900 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 12,467 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 13,717 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.48 ($4,800)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.61 ($6,112)
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 14,060 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 12,049 shares (to pay taxes)
Page 11 of 23 · 459 filings